Andrew Bissmeyer is a finance professional with extensive experience in the pharmaceutical industry, particularly roles at Eli Lilly and Company. Starting as a Strategy Intern at Delta Faucet Company, Andrew progressed to various positions at Eli Lilly, including Advisor in the Business Transformation Group and Consultant in Managed Healthcare Services. Key achievements involved integrating analytics into resource allocation decisions and leading financial planning for oncology research and development. Andrew also conducted financial analysis for investment opportunities and supported early-stage portfolio optimization as a Senior Financial Analyst. Andrew holds a Bachelor of Science in Finance and an MBA from the Kelley School of Business at Indiana University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices